Choosing the best drug for a particular patient Whichever approach you use in beginning (or changing) antihypertensive therapy, you should evaluate your patient for characteristics that will predict a favorable or unfavorable response (Table 2). Table 2. Factors To Consider When Choosing An Antihypertensive Agent Dosing Frequency Quality Of Life Cost Possibility Of Pregnancy Age [...]
(British Approved Name, US Adopted Name, rINN) Drug Nomenclature International Nonproprietary Names (INNs) in main languages (French, Latin, Russian, and Spanish): Synonyms: Alpha-methyldopa; MK-351; Methyldopa; Methyldopum; Methyldopum Hydratum; Metildopa; Metyldopa; Metyylidopa BAN: Methyldopa USAN: Methyldopa INN: Methyldopa [rINN (en)] INN: Metildopa [rINN (es)] INN: Méthyldopa [rINN (fr)] INN: Methyldopum [rINN (la)] INN: Метилдопа [rINN (ru)] [...]
Hypertension in pregnancy requires treatment that balances optimal outcomes for both mother and fetus. Hypertension during pregnancy is the second leading cause of maternal death, accounting for 15% of pregnancy-associated mortality in the United States. Approximately 8% of pregnancies are complicated by hypertension. Maternal complications of untreated hypertension during pregnancy include hepatic failure, acute renal [...]
